209 related articles for article (PubMed ID: 34497118)
1. Pubertal Suppression, Bone Mass, and Body Composition in Youth With Gender Dysphoria.
Navabi B; Tang K; Khatchadourian K; Lawson ML
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34497118
[TBL] [Abstract][Full Text] [Related]
2. Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents.
Vlot MC; Klink DT; den Heijer M; Blankenstein MA; Rotteveel J; Heijboer AC
Bone; 2017 Feb; 95():11-19. PubMed ID: 27845262
[TBL] [Abstract][Full Text] [Related]
3. Bone Development in Transgender Adolescents Treated With GnRH Analogues and Subsequent Gender-Affirming Hormones.
Schagen SEE; Wouters FM; Cohen-Kettenis PT; Gooren LJ; Hannema SE
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4252-63. PubMed ID: 32909025
[TBL] [Abstract][Full Text] [Related]
4. The effect of GnRH analogue treatment on bone mineral density in young adolescents with gender dysphoria: findings from a large national cohort.
Joseph T; Ting J; Butler G
J Pediatr Endocrinol Metab; 2019 Oct; 32(10):1077-1081. PubMed ID: 31472062
[TBL] [Abstract][Full Text] [Related]
5. Short-term outcomes of pubertal suppression in a selected cohort of 12 to 15 year old young people with persistent gender dysphoria in the UK.
Carmichael P; Butler G; Masic U; Cole TJ; De Stavola BL; Davidson S; Skageberg EM; Khadr S; Viner RM
PLoS One; 2021; 16(2):e0243894. PubMed ID: 33529227
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
Lem AJ; van der Kaay DC; Hokken-Koelega AC
J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
[TBL] [Abstract][Full Text] [Related]
7. Individualized evaluation of lumbar bone mineral density and bone mineral apparent density in children and adolescents.
Duran I; Martakis K; Rehberg M; Semler O; Schoenau E
Arch Osteoporos; 2018 Oct; 13(1):117. PubMed ID: 30374788
[TBL] [Abstract][Full Text] [Related]
8. Physical changes, laboratory parameters, and bone mineral density during testosterone treatment in adolescents with gender dysphoria.
Stoffers IE; de Vries MC; Hannema SE
J Sex Med; 2019 Sep; 16(9):1459-1468. PubMed ID: 31405768
[TBL] [Abstract][Full Text] [Related]
9. Trabecular Bone Score Reference Values for Children and Adolescents According to Age, Sex, and Ancestry.
Kalkwarf HJ; Shepherd JA; Hans D; Gonzalez Rodriguez E; Kindler JM; Lappe JM; Oberfield S; Winer KK; Zemel BS
J Bone Miner Res; 2022 Apr; 37(4):776-785. PubMed ID: 35118727
[TBL] [Abstract][Full Text] [Related]
10. Early Hormonal Treatment Affects Body Composition and Body Shape in Young Transgender Adolescents.
Klaver M; de Mutsert R; Wiepjes CM; Twisk JWR; den Heijer M; Rotteveel J; Klink DT
J Sex Med; 2018 Feb; 15(2):251-260. PubMed ID: 29425666
[TBL] [Abstract][Full Text] [Related]
11. Low Bone Mineral Density in Early Pubertal Transgender/Gender Diverse Youth: Findings From the Trans Youth Care Study.
Lee JY; Finlayson C; Olson-Kennedy J; Garofalo R; Chan YM; Glidden DV; Rosenthal SM
J Endocr Soc; 2020 Sep; 4(9):bvaa065. PubMed ID: 32832823
[TBL] [Abstract][Full Text] [Related]
12. Progressive bone impairment with age and pubertal development in neurofibromatosis type I.
Rodari G; Scuvera G; Ulivieri FM; Profka E; Menni F; Saletti V; Esposito S; Bergamaschi S; Ferrante E; Eller-Vainicher C; Esposito S; Arosio M; Giavoli C
Arch Osteoporos; 2018 Aug; 13(1):93. PubMed ID: 30151698
[TBL] [Abstract][Full Text] [Related]
13. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones.
van der Loos MATC; Vlot MC; Klink DT; Hannema SE; den Heijer M; Wiepjes CM
JAMA Pediatr; 2023 Dec; 177(12):1332-1341. PubMed ID: 37902760
[TBL] [Abstract][Full Text] [Related]
14. Proandrogenic and Antiandrogenic Progestins in Transgender Youth: Differential Effects on Body Composition and Bone Metabolism.
Tack LJW; Craen M; Lapauw B; Goemaere S; Toye K; Kaufman JM; Vandewalle S; T'Sjoen G; Zmierczak HG; Cools M
J Clin Endocrinol Metab; 2018 Jun; 103(6):2147-2156. PubMed ID: 29672753
[TBL] [Abstract][Full Text] [Related]
15. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
[TBL] [Abstract][Full Text] [Related]
16. Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria.
Klink D; Caris M; Heijboer A; van Trotsenburg M; Rotteveel J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E270-5. PubMed ID: 25427144
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the trabecular bone score in 35 children and adults with X-linked hypophosphatemic rickets.
de Paula Colares Neto G; Pereira RMR; Alvarenga JC; Takayama L; de Assis Funari MF; Martin RM
J Bone Miner Metab; 2023 Sep; 41(5):666-672. PubMed ID: 37418074
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study.
Goulding A; Jones IE; Taylor RW; Williams SM; Manning PJ
J Pediatr; 2001 Oct; 139(4):509-15. PubMed ID: 11598596
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal bone mineral content and density in Rett syndrome and their contributing factors.
Jefferson A; Fyfe S; Downs J; Woodhead H; Jacoby P; Leonard H
Bone; 2015 May; 74():191-8. PubMed ID: 25659951
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin and bone metabolism in adolescent girls with anorexia nervosa and healthy adolescents.
Misra M; Miller KK; Stewart V; Hunter E; Kuo K; Herzog DB; Klibanski A
J Clin Endocrinol Metab; 2005 Sep; 90(9):5082-7. PubMed ID: 15998770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
